Recent advances in the phencyclidine model of schizophrenia

Keyphrases

• N-methyl-D-aspartate Receptor (NMDAR) 100%
• Neurotransmission 100%
• Schizophrenia 100%
• Phencyclidine 100%
• Schizophrenia Models 100%
• Recent Advances 100%
• Induced Psychosis 100%
• Schizophrenic Patients 66%
• Psychotomimetic Effects 66%
• Amphetamine 66%
• Receptor-mediated 66%
• Dose-ranging 66%
• N-methyl-D-aspartate 33%
• Molecular Mechanism 33%
• Serum Concentration 33%
• Binding Site 33%
• Pathophysiology 33%
• Specific Binding 33%
• Hallucinations 33%
• Dust 33%
• Molecular Targets 33%
• Neurobehavior 33%
• Serum Levels 33%
• Neuropsychological Deficits 33%
• N-methyl-D-aspartate Receptor Antagonist 33%
• Aetiology of Schizophrenia 33%
• Clinical Dose 33%
• Dissociative Anesthetics 33%
• Induced Effect 33%
• Clinical Serum 33%
• Excitatory Amino Acid Transporter 33%
• Psychotomimetic 33%
• Intravenous Ketamine 33%
• CSF Levels 33%
• Non-competitive Inhibition 33%
• Psychomotor Retardation 33%
• Angels 33%
• Emotional Withdrawal 33%
• Paranoia 33%
• Formal Thought Disorder 33%

Neuroscience

• Eicosanoid Receptor 100%
• Dementia Praecox 100%
• Phencyclidine 100%
• Aspartic Acid 83%
• Neurotransmission 50%
• Psychotomimetic 50%
• Levoamphetamine 33%
• Anesthetics 16%
• Binding Site 16%
• Ketamine 16%
• Hallucination 16%
• Etiology of Schizophrenia 16%
• Thought Disorder 16%
• Excitatory Amino Acid Receptor 16%
• Dissociative 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Phencyclidine 100%
• Aspartic Acid 83%
• Psychotomimetic 50%
• Symptom 16%
• Binding Site 16%
• Pathophysiology 16%
• Molecular Target 16%
• Anesthetic Agent 16%
• Ketamine 16%
• Hallucination 16%
• Excitatory Amino Acid Receptor 16%
• Thought Disorder 16%
• Motor Retardation 16%